Trials that use: Fisher exact test
New to this method? Read the tutorial →
5,849 results
- HORIZON 2Independent statistical analysis of A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01633814).
- Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05175599).
- HPV Vaccine Intervention for Young Sexual Minority Men: Complete Statistical AnalysisIndependent statistical analysis of HPV Vaccine Intervention for Young Sexual Minority Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032106).
- HRVIndependent statistical analysis of Heart Rate Variability in Trauma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00795535).
- HSCT for High Risk Inherited Inborn Errors: Complete Statistical AnalysisIndependent statistical analysis of HSCT for High Risk Inherited Inborn Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383448).
- HSG and Tubal Patency Study: Complete Statistical AnalysisIndependent statistical analysis of HSG and Tubal Patency Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02146248).
- HSIIndependent statistical analysis of Home Safety Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06216327).
- HSPvsHSPASIIndependent statistical analysis of Hot Snare Versus Hot Snare Polypectomy With Saline Injection for Colorectal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HUCSIndependent statistical analysis of Human Use Condition Study- Evaluation of Implanted Leads in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320849).
- HUM21469Independent statistical analysis of Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130061).
- Human Factor Validation of Pediatric Mobility Device: Complete Statistical AnalysisIndependent statistical analysis of Human Factor Validation of Pediatric Mobility Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714256).
- Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: Complete Statistical AnalysisIndependent statistical analysis of Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: Complete Statistical AnalysisIndependent statistical analysis of Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HUMBOLDTIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HVTN 120Independent statistical analysis of Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants: primary endpoint results, effect estimate with confidence interval,…
- HW005Independent statistical analysis of Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609842).
- HyCoSyIndependent statistical analysis of Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hydrocortisone for BPD: Complete Statistical AnalysisIndependent statistical analysis of Hydrocortisone for BPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01353313).
- Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04372017).
- Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hyp-hOPIndependent statistical analysis of Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HYPERIONIndependent statistical analysis of Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- HyperlinkIndependent statistical analysis of Home Blood Pressure Telemonitoring and Case Management to Control Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00781365).
- hyperPOCIndependent statistical analysis of Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hypertonic Resuscitation Following Traumatic Injury: Complete Statistical AnalysisIndependent statistical analysis of Hypertonic Resuscitation Following Traumatic Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00316017).
- Hypofractionated IMRT With Temozolomide for HGG: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated IMRT With Temozolomide for HGG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02082119).
- Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: primary endpoint results, effect estimate with confidence…
- I-SCREENIndependent statistical analysis of Increasing Screening for Cancer Using EHR-Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06177795).
- iAIM EDUIndependent statistical analysis of Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis: Complete Statistical AnalysisIndependent statistical analysis of Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05399641).
- Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib in Combination With GA101 (Obinutuzumab) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IBSCIIndependent statistical analysis of The Relationship Between Irisin and Bone Health in Individuals With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IC/BPSIndependent statistical analysis of Real-world Evidence Study on Cystistat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05544695).
- ICEIndependent statistical analysis of Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00220740).
- ICIP-SAIndependent statistical analysis of Invasive Candidiasis in Saudi ICUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01490684).
- iCLAS™ for Persistent Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of iCLAS™ for Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04061603).
- ICONIC-TOTALIndependent statistical analysis of A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet):…